top of page
X-Ray Results

Our Advisors

sheng luo.jpg

Sheng Luo

Dr. Luo is full professor in Department of Biostatistics & Bioinformatics at Duke University. Dr. Luo is a leading expert in latent variable modeling, multivariate longitudinal data analysis, functional data analysis methods, survival analysis, and medical imaging analysis. He has more than 100 peer-reviewed articles on a variety of statistical topics and neurodegenerative diseases.


Dr. Luo has received multiple NIH grants as PI and co-PI to develop novel statistical methodology for complex clinical, imaging, and genetic data. He is also PI of multiple projects regarding various neurodegenerative disorders data analysis, rating scale development, validation, and translation funded by Parkinson’s Foundation, International Parkinson and Movement Disorder Society, and CHDI Foundation.

youwen he.jpg

You-Wen He

Experienced Professor with a demonstrated history of working Medical Center, Hospital & Biotech industry. Skilled in Translational Research, Cancer Immunotherapy, Vaccines, and Molecular Biology. Strong education professional with a Postdoctoral Fellow focused in Immunology from HHMI, University of Washington.

Dr. You-Wen He received his M.D. from the Fourth Military Medical University in 1986 in China and his Ph.D. in Immunology from the University of Miami School of Medicine in 1996. He completed his postdoctoral training in Dr. Michael J. Bevan’s laboratory at HHMI/University of Washington and took an Assistant Professor position in the Department of Immunology at Duke University Medical Center in year 2000. Dr. He is currently a Professor of Immunology at Duke University Medical Center. His lab has been studying T cell biology in health and diseases. The current effort in his lab is focused on developing new strategies to treat cancers using personalized immunotherapies. His lab is examining how antibodies/antagonists to complement receptors and the cytokine IL-10 are used to treat different tumors in animal models and human. Dr. He is also leading three highly personalized cancer immunotherapy clinical trials treating patients with glioblastoma multiforme and advanced solid tumors. He studies the functional role of the fundamental intracellular processes apoptosis and autophagy in T lymphocyte function.

bottom of page